Benitec Biopharma Earnings Estimate
| BNTC Stock | USD 12.12 0.47 4.03% |
Benitec Biopharma Revenue Breakdown by Earning Segment
By analyzing Benitec Biopharma's earnings estimates, investors can diagnose different trends across Benitec Biopharma's analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about (338.6 K). The current year's Pretax Profit Margin is expected to grow to -284.95Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.
Benitec Biopharma Earnings per Share Projection vs Actual
About Benitec Biopharma Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Benitec Biopharma earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Benitec Biopharma estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Benitec Biopharma fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -205.4 M | -215.6 M | |
| Retained Earnings Total Equity | -105 M | -99.7 M | |
| Earnings Yield | (0.10) | (0.11) | |
| Price Earnings Ratio | (10.06) | (10.56) | |
| Price Earnings To Growth Ratio | 0.21 | 0.15 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Biotechnology sector continue expanding? Could Benitec diversify its offerings? Factors like these will boost the valuation of Benitec Biopharma. Projected growth potential of Benitec fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Benitec Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 0.125 | Return On Assets | Return On Equity |
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Benitec Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Benitec Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Benitec Biopharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.